Loading...
•
Dec 31, 2019
Globus Medical Q4 2019 Earnings Report
Globus Medical's Q4 2019 results showed revenue growth and increased profitability.
Key Takeaways
Globus Medical reported an 8.0% increase in worldwide sales to $211.7 million for the fourth quarter of 2019. The company's net income increased by 23.9% to $45.5 million, with diluted EPS at $0.44 and non-GAAP diluted EPS at $0.49. The company confirmed full year 2020 sales guidance of $850 million and non-GAAP diluted earnings per share of $1.82.
Worldwide sales increased by 8.0% to $211.7 million.
Net income for the quarter was $45.5 million, representing 21.5% of sales.
Diluted EPS reached $0.44, while non-GAAP diluted EPS was $0.49.
Non-GAAP adjusted EBITDA was 34.3% of sales.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The Company today confirmed full year 2020 guidance with expected sales of $850 million and non-GAAP diluted earnings per share of $1.82.
Positive Outlook
- Expected sales of $850 million
- Non-GAAP diluted earnings per share of $1.82
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...